Article Text

Download PDFPDF
53 Effects Of GLP-1 eluting stem cell therapy on collagen remodelling in a porcine model of myocardial infarction
  1. E J Wright1,
  2. K A Farrell1,
  3. N Malik1,
  4. C Wallrapp2,
  5. P Geigle2,
  6. A L Lewis3,
  7. P W Stratford3,
  8. C M Holt1
  1. 1Cardiovascular Research Group, University of Manchester, UK
  2. 2CellMed AG, Alzenau, Germany
  3. 3Biocompatibles UK Ltd, Surrey, UK


Glucagon-like peptide-1 (GLP-1) is an incretin hormone with cardioprotective effects. Human stem cells (hMSCs) secreting a GLP-1 fusion protein and encapsulated in alginate (GLP-1 CellBeads) have been developed as a novel therapeutic. This study investigated the effects of GLP-1 CellBeads on post-MI healing in a porcine model. GLP-1 CellBeads were delivered to coronary artery branches, creating micro-infarcts and mild LV dysfunction. Cell-free beads (empty) and CellBeads containing hMSCs but not secreting GLP-1 (hMSC-beads) were delivered as controls. Left ventricular (LV) function, infarct size, myocyte cross-sectional area, total collagen content (picrosirius red staining) and collagen -1 and -3 levels (qRT-PCR) were analysed to determine therapeutic potential. Four weeks post-MI, only GLP-1 CellBead treatment produced significantly improved LV function compared to 30 min post-MI (44.00%±1.29% vs 49.75%±1.03%, p<0.001). This was also associated with less infarct (3.21%±0.90%) compared to control groups (empty; 17.70%±4.69% vs hMSC-beads: 16.71%±1.60%, p<0.05). Total collagen content (infarct) was increased following delivery of hMSC-beads and GLP-1 CellBeads compared to empty beads (6.87%±2.92% vs 19.63%±1.37% vs 16.88%±6.61%, p<0.05), with increases in collagen 1 and 3 mRNA synthesis observed in all groups. Border zone myocytes were significantly larger in all groups compared to control (non-infarcted) tissue (empty: 378.4±31.3; hMSC-beads: 364.6±15.7; GLP-1 CellBeads: 344.7±38.9; control: 132.7±13.0), with no differences in remote regions. Delivery of GLP-1 CellBeads restored LV function, limited infarct size, enhanced collagen scar formation, altered collagen mRNA synthesis and decreased border myocyte size. Effects observed were due to a combination of GLP-1 and paracrine factors released from the hMSCs.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.